John K Forrest
MD, FACC, FSCAI
Associate Professor of Medicine (Cardiovascular Medicine); Director of Interventional Cardiology, Cardiovascular Medicine; Director of Structural Heart Disease, Yale Medicine; Director, Structural Heart Disease Program, Cardiovascular Medicine
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Education & Training
- FellowshipYale University School of Medicine (2012)
- FellowshipYale University (2010)
- ResidencyYale-New Haven Hospital/Traditional Program (2008)
- InternshipYale-New Haven Hospital/Traditional Program (2006)
- MDYale University School of Medicine (2005)
- BSBowdoin College, History and Biochemistry
Activities
- Transcatheter Versus Surgical Aortic Valve Replacement in Aortic Stenosis Patients at Low Surgical Risk: 3-year Outcomes from the Evolut Low Risk TrialHangzhou, China 2023Transcatheter Versus Surgical Aortic Valve Replacement in Aortic Stenosis Patients at Low Surgical Risk: 3-year Outcomes from the Evolut Low Risk Trial
- EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART)Boston, MA, United States 2022EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART)
- TAVR and Bicuspid Aortic Valve Disease: Update on the EvidenceBoston, MA, United States 2022TAVR and Bicuspid Aortic Valve Disease: Update on the Evidence
- Cerebral Embolic Protection in TAVR: Selective use in Vulnerable PatientsBoston, MA, United States 2022Cerebral Embolic Protection in TAVR: Selective use in Vulnerable Patients
- The Evolut Supra‐Annular, Self‐Expanding Transcatheter Aortic Bioprosthesis Provides Symmetric Scaffolding for Optimal Leaflet Coaptation Despite Variable Annular MorphologyBoston, MA, United States 2022The Evolut Supra‐Annular, Self‐Expanding Transcatheter Aortic Bioprosthesis Provides Symmetric Scaffolding for Optimal Leaflet Coaptation Despite Variable Annular Morphology
- My "Best Practice’" Routine Bicuspid TAVRMiami, FL, United States 2022My "Best Practice’" Routine Bicuspid TAVR
- TAVR in Bicuspid Valves Technical Pearls: Valve Choice, Sizing, and PositioningChicago, IL, United States 2022TAVR in Bicuspid Valves Technical Pearls: Valve Choice, Sizing, and Positioning
- Progress in Self-Expanding TAVR: Evolut PRO Plus and BeyondChicago, IL, United States 2022Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond
- Cerebral Embolic Protection and TAVROrlando, FL, United States 2021Cerebral Embolic Protection and TAVR
- TAVR for Bicuspid Aortic Stenosis: Temporal Trends and OutcomesHangzhou, China 2021TAVR for Bicuspid Aortic Stenosis: Temporal Trends and Outcomes
- Between a Rock and a Hard Place: Calcium, Calcium, and More CalciumMiami, FL, United States 2021Between a Rock and a Hard Place: Calcium, Calcium, and More Calcium
- Balancing Contemporary Bicuspid DataMiami, FL, United States 2021Balancing Contemporary Bicuspid Data
- Complete 2-year Follow-Up from Evolut Low Risk TrialMiami, FL, United States 2021Complete 2-year Follow-Up from Evolut Low Risk Trial
- TAVR in Women and BicuspidsVirtual Meeting 2021TAVR in Women and Bicuspids
- Management of Coronary Disease Pre-and Post TAVR: Guidelines, Tips and TricksOn-line Virtual Conference 2020Management of Coronary Disease Pre-and Post TAVR: Guidelines, Tips and Tricks
- TAVR Optimization Strategies in Complex Anatomies: BicuspidVirtual Conference 2020TAVR Optimization Strategies in Complex Anatomies: Bicuspid
- Updates of Evolut Low Risk TrialHangzhou, China 2020Updates of Evolut Low Risk Trial
- Primary Results of Evolut Low Risk Bicuspid StudyHangzhou, China 2020Primary Results of Evolut Low Risk Bicuspid Study
- Blueprint for Bicuspid Treatment: TAVR Implant Strategies for Bicuspid PatientsVirtual Conference 2020Evolut Platform: Design Features, Outcomes, Implantation Tips and Tricks and Future Visions
- Critical Review of Evidence: TAVR in Low Risk Bicuspid PatientsVirtual Conference 2020Critical Review of Evidence: TAVR in Low Risk Bicuspid Patients
- TAVR Foundations for FellowsSan Francisco, CA, United States 2019TAVR Foundations for Fellows
- TAVR in Bicuspid Aortic ValvesSan Francisco, CA, United States 2019TAVR in Bicuspid Aortic Valves
- TAVR with High Risk for Coronary ObstructionSan Francisco, CA, United States 2019TAVR with High Risk for Coronary Obstruction
- Incidence and Outcomes of Patient-Prosthesis Mismatch Following Self-expanding Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT RegistrySan Francisco, CA, United States 2019Incidence and Outcomes of Patient-Prosthesis Mismatch Following Self-expanding Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry
- Latest Clinical Data in Bicuspid DiseaseChicago, IL, United States 2019Latest Clinical Data in Bicuspid Disease
- Transcatheter Therapies: Potential RealizedNew Orleans, LA, United States 2019Transcatheter Therapies: Potential Realized
- Valvular Heart Disease in 2019: A Field TransformedNew Orleans, LA, United States 2019Valvular Heart Disease in 2019: A Field Transformed
- Con: Cerebral Embolic Protection is a Niche ConceptLas Vegas, NV, United States 2019Con: Cerebral Embolic Protection is a Niche Concept
- New Technologies for Brain Protection During TAVRLas Vegas, NV, United States 2019New Technologies for Brain Protection During TAVR
- TAVR in Patients with a Bicuspid AnatomyNew York, NY, United States 2019TAVR in Patients with a Bicuspid Anatomy
- Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Bicuspid Morphology: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryWashington, DC, United States 2019Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Bicuspid Morphology: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
- TAVR Foundations for FellowsSan Diego, CA, United States 2018TAVR Foundations for Fellows
- The Road to Perdition: Severe Aortic Stenosis with Bicuspid Valve DiseaseSan Diego, CA, United States 2018The Road to Perdition: Severe Aortic Stenosis with Bicuspid Valve Disease
- Paravalvular Leak Post-TAVRSan Diego, CA, United States 2018Paravalvular Leak Post-TAVR
- Coronary Obstruction After TAVRSan Diego, CA, United States 2018Coronary Obstruction After TAVR
- 30-Day Outcomes Following Transcatheter Aortic Valve Replacement with the Evolut PRO Valve in Commercial Use: Report from the STS/ACC TVT RegistrySan Diego, CA, United States 201830-Day Outcomes Following Transcatheter Aortic Valve Replacement with the Evolut PRO Valve in Commercial Use: Report from the STS/ACC TVT Registry
- Cerebral Embolic Protection During TAVRSan Diego, CA, United States 2018Cerebral Embolic Protection During TAVR
- Structural Heart Disease in 2018: Moving from TAVR to TMVR and MoreFarmington, CT, United States 2018Structural Heart Disease in 2018: Moving from TAVR to TMVR and More
- Debate: Cerebral Embolic Protection Should be Used in All (Most) CasesChicago, IL, United States 2018Debate: Cerebral Embolic Protection Should be Used in All (Most) Cases
- The Evolut PRO TAVR System: Confronting the Issues (Valve Sizing, New Pacemakers, Paravalvular Leak, and Extreme CalcificationChicago, IL, United States 2018The Evolut PRO TAVR System: Confronting the Issues (Valve Sizing, New Pacemakers, Paravalvular Leak, and Extreme Calcification
- Challenging Structural Cases by the Experts: Predicting and Managing Coronary Obstruction during TAVROrlando, FL, United States 2018Challenging Structural Cases by the Experts: Predicting and Managing Coronary Obstruction during TAVR
- 1-Year Outcomes With the Evolut PRO Self-Expanding Repositionable Transcatheter Aortic Valve With Pericardial WrapOrlando, FL, United States 20181-Year Outcomes With the Evolut PRO Self-Expanding Repositionable Transcatheter Aortic Valve With Pericardial Wrap
- Evolut R TAVR - Technology Review Including Evolut 34mm and PRODenver, CO, United States 2017Evolut R TAVR - Technology Review Including Evolut 34mm and PRO
- Low Incidence of Paravalvular Leak at 6 Months with the New Self-Expanding Repositionable Transcatheter Aortic Valve with Pericardial WrapDenver, CO, United States 2017Low Incidence of Paravalvular Leak at 6 Months with the New Self-Expanding Repositionable Transcatheter Aortic Valve with Pericardial Wrap
- TAVR Shift to Intermediate-Risk Patients: Practical Considerations for the Heart Team and HospitalsDenver, CO, United States 2017TAVR Shift to Intermediate-Risk Patients: Practical Considerations for the Heart Team and Hospitals
- Evolut R Snapshots I - The New Evolut R PRO SystemChicago, IL, United States 2017Evolut R Snapshots I - The New Evolut R PRO System
- Ask the Experts - How Do I Manage These Challenge Case Scenarios?Chicago, IL, United States 2017Ask the Experts - How Do I Manage These Challenge Case Scenarios?
- Optimizing Post-Dilation with Self-Expanding Valves - Does Balloon Choice Matter?Chicago, IL, United States 2017Optimizing Post-Dilation with Self-Expanding Valves - Does Balloon Choice Matter?
- Will SURTAVI Change my Practice: TAVI for Patients with Intermediate Risk?Paris, IDF, France 2017Will SURTAVI Change my Practice: TAVI for Patients with Intermediate Risk?
- Recorded Case: Transcatheter Aortic Valve Replacement using Evolut Pro ValveParis, IDF, France 2017Recorded Case: Transcatheter Aortic Valve Replacement using Evolut Pro Valve
- Transcatheter Mitral Valve-in-Ring with Concomitant Para-Ring Leak ClosureParis, IDF, France 2017Transcatheter Mitral Valve-in-Ring with Concomitant Para-Ring Leak Closure
- How to Build a Successful Multidisciplinary Interventional Program: Balancing Pressures of Good Practice and Good ResearchNew Orleans, LA, United States 2017How to Build a Successful Multidisciplinary Interventional Program: Balancing Pressures of Good Practice and Good Research
- Procedural Perfection: Ideal TAVR Using the Evolut - All the Tips and TricksNew Orleans, LA, United States 2017Procedural Perfection: Ideal TAVR Using the Evolut - All the Tips and Tricks
- Managing Complex Paravalvular LeaksAtlanta, GA, United States 2017Managing Complex Paravalvular Leaks
- 30-Day Safety and Echocardiographic Outcomes Following Transcatheter Aortic Valve Replacement with the Self-Expanding Repositionable Evolut PRO SystemWashington, DC, United States 201730-Day Safety and Echocardiographic Outcomes Following Transcatheter Aortic Valve Replacement with the Self-Expanding Repositionable Evolut PRO System
- Next Generation TAVI TechnologiesPrague, Prague, Czech Republic 2017Next Generation TAVI Technologies
- How to Mitigate the Risk of PVL post TAVRPrague, Prague, Czech Republic 2017How to Mitigate the Risk of PVL post TAVR
- Transcatheter Aortic Valve Replacement in Women Versus Men: An Analysis of the CoreValve US Pivotal and Continued Access TrialsSan Francisco, CA, United States 2015Transcatheter Aortic Valve Replacement in Women Versus Men: An Analysis of the CoreValve US Pivotal and Continued Access Trials
- Current Status of TAVR with the Self-Expanding CoreValve SystemAtlanta, GA, United States 2015Current Status of TAVR with the Self-Expanding CoreValve System
- Debate: Is TAVR or SAVR More Appropriate for All Comers: ProAtlanta, GA, United States 2015Debate: Is TAVR or SAVR More Appropriate for All Comers: Pro
- Complex Cases Using a Self-Expanding TAVRAtlanta, GA, United States 2015Complex Cases Using a Self-Expanding TAVR
- US Perspective: Optimizing Patient Selection and Imaging for TAVRWashington, DC, United States 2014US Perspective: Optimizing Patient Selection and Imaging for TAVR
- A True Hybrid Case: Off-Pump CABG and TAVR (Direct Aortic Approach using a 31mm CoreValve) in Patient with Left Main Disease, Bicuspid Aortic Valve Stenosis, and Severe ThrombocytopeniaWashington, DC, United States 2014A True Hybrid Case: Off-Pump CABG and TAVR (Direct Aortic Approach using a 31mm CoreValve) in Patient with Left Main Disease, Bicuspid Aortic Valve Stenosis, and Severe Thrombocytopenia
- Transcatheter Aortic Valve Replacement 2014New London, CT, United States 2014Transcatheter Aortic Valve Replacement 2014
- Innovation: New Frontier in Implantable Therapies: Clinical Need, Regulatory Challenges, and Market OpportunitiesLondon, England, United Kingdom 2014Innovation: New Frontier in Implantable Therapies: Clinical Need, Regulatory Challenges, and Market Opportunities
- Focus of TAVR: Program, Patient Selections, and ComplicationsMedellín, Antioquia, Colombia 2013Focus of TAVR: Program, Patient Selections, and Complications
- Treating Iliac, SFA, and Critical Limb Ischemia - Patient Screening, Prognosis, Treatment Options and OutcomesMedellín, Antioquia, Colombia 2013Treating Iliac, SFA, and Critical Limb Ischemia - Patient Screening, Prognosis, Treatment Options and Outcomes
- Recorded Case: Retrograde RCA CTO via RV Marginal: The Beating CorsairMiami, FL, United States 2012Recorded Case: Retrograde RCA CTO via RV Marginal: The Beating Corsair
- Complex Carotid StentingOrlando, FL, United States 2011Complex Carotid Stenting
- Evaluation of everolimus-eluting and paclitaxel eluting stents in patients with jailed side branches: two-year results from the SPIRIT IV trialParis, IDF, France 2011Evaluation of everolimus-eluting and paclitaxel eluting stents in patients with jailed side branches: two-year results from the SPIRIT IV trial
- Device Choices for Percutaneous Aortic Paravalvular Leak ClosureVancouver, BC, Canada 2011Device Choices for Percutaneous Aortic Paravalvular Leak Closure
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
ACC Emerging Leadership Faculty | American College of Cardiology | 2019 |
Yale Advanced Emerging Leadership Program | 2017 | |
Fellow of the American College of Cardiology | 2016 | |
Yale-New Haven Hospital Nurses Choice Award | 2016 | |
Fellow of the Society for Cardiovascular Angiography and Interventions | 2015 | |
The John P. Peters Prize | Yale School of Medicine | 2005 |
NIH/NHLBI Student Research Grant Award | NIH/NHLBI | 2004 |
Yale Club of New Haven Scholar | Yale Club of New Haven | 2001, 2002, 2003, 2004 |
NIH Summer Research Fellowship Award | NIH | 2001 |
Professional Service
Organization | Role | Date |
---|---|---|
Yale New Haven Health System | Aortic Stenosis Care Signature Pathway | 2022 |
PROGRESS (TAVR for Moderate Aortic Stenosis and Cardiac Dysfunction) Trial | National/International Screening Committee | 2022 - Present |
China Valve (Hangzhou) | Moderator | 2022 - Present |
Structural Heart Advisory Board, Medtronic Inc | Board Member | 2022 - Present |
Structrual Heart Data Evidence and Publications Committee, Medtronic | Chair | 2022 - Present |
Yale University- Davenport College | Faculty Fellow at Davenport College Yale University | 2021 - Present |
HVC Research Leadership Committee | Executive Committee Member | 2021 - Present |
Yale New Haven Heath System | Lumedx Steering Committee | 2021 - Present |
PROGRESS (TAVR for Moderate Aortic Stenosis and Cardiac Dysfunction) Trial | National/International Steering Committee | 2021 - Present |
EVOLUT R Low Risk Randomized Clinical Trial | National/International Principal Investigator | 2021 - Present |
American College of Cardiology | STS/ACC TVT Mitral Risk Model Committee | 2021 - Present |
Transcatheter Valve Therapies (TVT) | Annual Meeting | 2021 - Present |
New England Structural Heart Consortium | Annual Meeting | 2021 - Present |
St. Thomas Day School | Chairman Board 2021-present | 2021 - Present |
New England Structural Heart Consortium | Annual Meeting | 2021 - Present |
New England Structural Heart Consortium | Annual Meeting | 2021 - Present |
Journal of American College of Cardiology (JACC) | Guest Editor | 2021 - Present |
Journal of the American Medical Association (JAMA) | Reviewer | 2021 - Present |
Journal of the Society for Cardiovascular Angiography (JSCAI) | Editorial Board Member | 2021 - Present |
Journal of the Society for Cardiovascular Angiography (JSCAI) | Reviewer | 2021 - Present |
Journal of American College of Cardiology (JACC) | Reviewer | 2020 - Present |
JAMA Cardiology | Reviewer | 2020 - Present |
St. Thomas Day School | Board Vice President | 2019 - 2021 |
Society for Cardiovascular Angiography and Interventions (SCAI) | Annual Meeting | 2019 - 2020 |
Transcatheter Cardiovascular Therapeutics (TCT) | Annual Meeting Abstract Review Committee | 2019 - Present |
Society for Cardiovascular Angiography and Interventions | Annual Meeting | 2019 - Present |
Transcatheter Cardiovascular Therapeutics | Abstract Selection Committee | 2019 - Present |
Global Advisory Board, Medtronic Inc | Board Member | 2019 - Present |
New England Structural Heart Annual Meeting | Co-Director | 2018 - Present |
New England Structural Heart Consortium | Board of Directors | 2018 - Present |
BICUSPID TAVR Clinical Trial | National Steering Committee | 2018 - 2020 |
BICUSPID TAVR Clinical Trial | National Screening Committee | 2018 - 2020 |
REFLECT 3 Clinical Trial | National Screening Committee | 2018 - 2020 |
Yale University School of Medicine | Mission Statement Committee | 2018 - 2019 |
New England Structural Heart Consortium | Founding Member | 2018 |
BICUSPID TAVR Clinical Trial | National Principal Investigator | 2018 - Present |
APOLLO Transcatheter Mitral Valve Replacement Clinical Trial | National Screening Committee | 2018 - Present |
APOLLO Transcatheter Mitral Valve Replacement Clinical Trial | National Steering Committee | 2018 - Present |
American College of Cardiology | STS/ACC TVT TAVR Risk Model Committee | 2018 - Present |
American College of Cardiology | Abstract Selection Committee: Aortic Valve Disease | 2018 - Present |
Transcatheter Cardiovascular Therapeutics (TCT) | Annual Meeting | 2018 - Present |
Transcatheter Valve Therapies | Annual meeting (late breaking clinical trials, cases, innovation, moderated posters) reviewer | 2018 - Present |
American College of Cardiology | Annual session Abstract Selection Committee Aorta Valve Disease | 2018 - Present |
Journal of American College of Cardiology - Cardiovascular Interventions (JACC- Intervenions) | Reviewer | 2018 - Present |
Yale University School of Medicine | Quality Committee | 2017 - 2019 |
Yale New Haven Health System | Yale New Haven Health Systems Quality Committee | 2017 - 2019 |
American College of Cardiology | TVT Dataset Update Working Group | 2017 - 2019 |
Yale New Haven Hospital | HVC/ED Collaborative | 2017 - Present |
TAVR UNLOAD Clinical Trial | National Screening Committee | 2017 - Present |
EVOLUT R Low Risk Randomized TAVR Trial | National Steering Committee | 2017 - Present |
Transcatheter Valve Therapies (TVT) | Annual Meeting | 2017 - Present |
American College of Cardiology | TVT Dataset Update | 2017 - Present |
Transcatheter Valve Therapies (TVT) | Abstract Grader | 2017 - Present |
Transcatheter Cardiovascular Therapies | Annual meeting Session Chair | 2017 - Present |
Transcatheter Valve Therapies | Annual meeting, Abstract Selection Committee | 2017 - Present |
Transcatheter Valve Therapies | Annual meeting Session Chair | 2017 - Present |
Aorta | Editorial Board Member | 2017 - Present |
US Advisory Board, Boston Scientific | Board Member | 2017 - Present |
TAVR 2.0 Clinical Trial | Chair of National Steering Committee | 2016 - 2018 |
TAVR 2.0 Clinical Trial | Chair of National Screening Committee | 2016 - 2017 |
Yale University School of Medicine | Heart Care Team | 2016 - Present |
TAVR 2.0 Clinical Trial | National Principal Investigator | 2016 - Present |
Structural Heart Advisory Board, Edwards Lifesciences | Board Member | 2016 - Present |
Yale-New Haven Hospital | Yale-New Haven Patient Experience Committee | 2015 - 2020 |
St. Thomas Day School | Member Board of Governor's | 2015 - 2019 |
FANTOM II Clinical Trial | Data Safety Monitoring Board (DSMB) | 2015 - 2018 |
ABLATE Clinical Trial | Clinical Event Committee (CEC) | 2015 - 2016 |
Yale University School of Medicine | Yale Medical Leadership Council | 2015 - Present |
Yale New Haven Hospital | Yale medical Leadership Committee (MLC/JLC) | 2015 - Present |
Medtronic | Medtronic Fundamentals of TAVR Fellows Course Co-Director | 2015 - Present |
Edwards | Edwards TAVR Fellows Course Co-Director | 2015 - Present |
Medtronic | Medtronic Advanced Users Evolut R Program Co-Chair | 2015 - Present |
American Journal of Cardiology, Catheterization and Cardiovascular Interventions | Reviewer | 2015 - Present |
Fundamentals of TAVR, Medtronic Inc | Co-Director | 2015 - Present |
DEFLECT III Clinical Trial | Clinical Event Committee (CEC) | 2014 - 2015 |
Transcatheter Valve Therapies (TVT) | Annual Meeting | 2014 - Present |
DEFLECT II Clinical Trial | Clinical Event Committee (CEC) | 2013 - 2014 |
Transcatheter Cardiovascular Therapeutics (TCT) | Annual Meeting | 2013 - Present |
DEFLECT I Clinical Trial | Clinical Event Committee (CEC) | 2012 - 2013 |
Departments & Organizations
- Cardiovascular Medicine
- Internal Medicine
- Interventional Cardiology Program
- Structural Heart Disease Program
- Yale Medicine